While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...

Recipe photos: Morgan Hunt Glaze and Jen Causey. EatingWell design.

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.

There are additional considerations that physicians need to consider when prescribing GLP-1s to patients with disabilities or ...

Risk of suicidality wasn't higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two ...

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

In recent years, the pursuit of natural solutions to enhance metabolic health has gained prominence. Individuals are increasingly looking for ways to optimize their wellness without resorting to harsh ...